Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences
Drug-induced hyperlipasemia
Other Resources UpToDate PubMed

Drug-induced hyperlipasemia

Contributors: Michael W. Winter MD, Paritosh Prasad MD
Other Resources UpToDate PubMed

Synopsis

Drug-induced hyperlipasemia refers to an elevation of lipase attributed to a medication or other drug exposure. Importantly, this does not indicate pancreatitis, as pancreatitis requires 2 of 3 criteria: (1) lipase over 3 times the upper limit of normal, (2) imaging findings suggestive of pancreatitis, and (3) clinical examination consistent with pancreatitis.

Narcotics, thiazide diuretics, oral contraceptives, adrenocorticotropic hormone, and cholinergics are commonly associated with hyperlipasemia. For a list of medications associated with drug-induced hyperlipasemia, see Drug Reaction Data below.

Benign lipasemia will be asymptomatic. If lipase is elevated in the setting of drug-induced pancreatitis, patients will often present with nausea, emesis, and mid-epigastric abdominal pain radiating to the back.

Codes

ICD10CM:
R74.8 – Abnormal levels of other serum enzymes
T50.995A – Adverse effect of other drugs, medicaments and biological substances, initial encounter

SNOMEDCT:
278993004 – Drug-induced
441957004 – High lipase level in serum

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Subscription Required

References

Subscription Required

Last Reviewed:01/01/2018
Last Updated:08/21/2018
Copyright © 2024 VisualDx®. All rights reserved.
Drug-induced hyperlipasemia
Print  
A medical illustration showing key findings of Drug-induced hyperlipasemia
Copyright © 2024 VisualDx®. All rights reserved.